Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Myriad Genetics
Salt Lake City, Utah, USAmyriad.com ↗
- Ownership
- Public · MYGN
- Employees
- ~2700
- Development stage
- Commercial
01
Overview
Myriad Genetics has pioneered commercial genetic testing since the early days of BRCA gene discovery. The company offers a broad portfolio of clinically validated molecular diagnostic tests for hereditary cancer risk assessment, psychiatric pharmacogenomics, reproductive carrier screening, and disease prognosis. Its products are widely adopted in clinical practice globally.
- Therapeutic areas
- Women's HealthOncologyPsychiatry
- Modalities
- Genetic testing (germline and somatic)Molecular diagnostics
- Industry
- Molecular Diagnostics
02
Partnerships
Notable collaborations with academic institutions such as University of UtahPartnerships with healthcare providers worldwide
03
Financials
- Market cap
- $601.6M
- Total revenue
- $824.5M
- Enterprise value
- $703.9M
Beyond the preview
Go deeper on Myriad Genetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myriad Genetics.